COYA · Coya Therapeutics, Inc.
Market Cap
$114.98M
Shares
23.46M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K/A | 2026-08-07 | 2026-03-29 | |
| 8-K | 2026-06-25 | — | |
| DEF 14A | 2026-05-13 | 2026-06-25 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-04-02 | 2026-03-29 | |
| 10-K | 2026-03-16 | 2025-12-31 | |
| 8-K | 2026-03-16 | — | |
| 8-K | 2026-01-30 | 2026-01-29 | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-12-17 | 2025-12-16 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-10-27 | 2025-10-23 | |
| 8-K | 2025-09-02 | 2025-08-29 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-07-01 | 2025-06-30 | |
| 8-K | 2025-06-26 | — | |
| DEF 14A | 2025-05-16 | 2025-06-26 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 10-K/A | 2025-04-28 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-11-05 | 2024-11-01 | |
| 8-K | 2024-10-31 | 2024-10-28 | |
| 8-K | 2024-10-29 | — | |
| 8-K | 2024-10-22 | 2024-10-21 | |
| 8-K | 2024-08-19 | 2024-08-16 | |
| 8-K | 2024-08-12 | — | |
| 10-Q | 2024-08-12 | 2024-06-30 | |
| 8-K | 2024-07-15 | 2024-07-12 | |
| 8-K | 2024-06-05 | 2024-06-04 | |
| 8-K | 2024-05-20 | 2024-05-17 | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-03-28 | 2024-05-08 | |
| 8-K | 2024-03-19 | — | |
| 10-K | 2024-03-19 | 2023-12-31 | |
| 8-K | 2024-01-19 | — | |
| 8-K | 2023-12-20 | 2023-12-19 |
Showing 1–50 of 73 filings
Key facts
CIK
1835022
CUSIP
22407B108
13F (30d)
49 filings
49 filers
Visit website
Investor relations